322 related articles for article (PubMed ID: 30276966)
41. Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma.
Nie GJ; Liu J; Zou AM; Zhan SF; Liang JK; Sui Y; Chen YN; Yao WS
J Clin Lab Anal; 2022 Apr; 36(4):e24277. PubMed ID: 35238419
[TBL] [Abstract][Full Text] [Related]
42. Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
Lv Z; Lei T
BMC Cancer; 2020 Jan; 20(1):56. PubMed ID: 31987030
[TBL] [Abstract][Full Text] [Related]
43. Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas.
Jin X; Zheng Y; Chen Z; Wang F; Bi G; Li M; Liang J; Sui Q; Bian Y; Hu Z; Qiao Y; Xu S
Cancer Med; 2021 Dec; 10(23):8673-8692. PubMed ID: 34617407
[TBL] [Abstract][Full Text] [Related]
44. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
45. Systems biology analysis reveals new insights into invasive lung cancer.
Li D; Yang W; Arthur C; Liu JS; Cruz-Niera C; Yang MQ
BMC Syst Biol; 2018 Dec; 12(Suppl 7):117. PubMed ID: 30547817
[TBL] [Abstract][Full Text] [Related]
46. Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules.
Zhou D; Li YQ; Liu QX; Deng XF; Chen L; Li MY; Zhang J; Lu X; Zheng H; Dai JG
Cancer Med; 2024 Jun; 13(11):e7383. PubMed ID: 38864483
[TBL] [Abstract][Full Text] [Related]
47. Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Xie D; Luo X
Toxicol Appl Pharmacol; 2021 Feb; 412():115391. PubMed ID: 33387576
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.
Xiao J; Liu A; Lu X; Chen X; Li W; He S; He B; Chen Q
Sci Rep; 2017 May; 7(1):2027. PubMed ID: 28515486
[TBL] [Abstract][Full Text] [Related]
49. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
Li J; Wang B; Li X; Zhu Y
Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531
[TBL] [Abstract][Full Text] [Related]
50. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Ke H; Wu Y; Wang R; Wu X
Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
[TBL] [Abstract][Full Text] [Related]
51. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H
Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938
[TBL] [Abstract][Full Text] [Related]
52. Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma.
Li B; Huang Z; Yu W; Liu S; Zhang J; Wang Q; Wu L; Kou F; Yang L
Neoplasia; 2021 Jul; 23(7):704-717. PubMed ID: 34139453
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma.
Gu X; Huang X; Zhang X; Wang C
Int J Biol Sci; 2022; 18(13):4984-5000. PubMed ID: 35982906
[No Abstract] [Full Text] [Related]
54. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
Liu K; Kang M; Liao X; Wang R
PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
[TBL] [Abstract][Full Text] [Related]
56. Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component.
Kidokoro Y; Sakabe T; Haruki T; Kadonaga T; Nosaka K; Nakamura H; Umekita Y
Lung Cancer; 2020 Sep; 147():56-63. PubMed ID: 32673827
[TBL] [Abstract][Full Text] [Related]
57. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
Zhang H; Liu J; Fu X; Yang A
Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
[TBL] [Abstract][Full Text] [Related]
58. Gene expression-based clinical predictions in lung adenocarcinoma.
Xiong Y; Lei J; Zhao J; Feng Y; Qiao T; Zhou Y; Jiang T; Han Y
Aging (Albany NY); 2020 Aug; 12(15):15492-15503. PubMed ID: 32756002
[TBL] [Abstract][Full Text] [Related]
59. Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma.
Yan Y; Xu Z; Qian L; Zeng S; Zhou Y; Chen X; Wei J; Gong Z
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L630-L643. PubMed ID: 30604627
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive characterization of differentially expressed genes in thyroid cancer.
Wang J; Chi S; Huang Z; Ye X; Shi G; Chen D; Lou C
Future Oncol; 2017 Oct; 13(24):2159-2169. PubMed ID: 28984479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
